These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 34053953)

  • 1. Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China.
    Li J; Shen H; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
    Jpn J Infect Dis; 2022 Jan; 75(1):31-35. PubMed ID: 34053953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
    Lao CK; Tseng MC; Chiu CH; Chen NY; Chen CH; Chung WH; Liu TP; Lu JJ; Lai HC; Yang LY; Lee CH; Wu TS
    J Formos Med Assoc; 2022 Oct; 121(10):2109-2122. PubMed ID: 35811270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The species distribution and antimicrobial resistance profiles of Nocardia species in China: A systematic review and meta-analysis.
    Wang C; Sun Q; Yan J; Liao X; Long S; Zheng M; Zhang Y; Yang X; Shi G; Zhao Y; Wang G; Pan J
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011432. PubMed ID: 37428800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.
    Wei M; Wang P; Qu J; Li R; Liu Y; Gu L; Yang C
    J Glob Antimicrob Resist; 2017 Dec; 11():183-187. PubMed ID: 28870771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
    Ölmez S; Otlu B; Şener B; Sancak B
    Mikrobiyol Bul; 2023 Jan; 57(1):108-118. PubMed ID: 36636850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
    Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
    J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
    Wei M; Xu X; Yang J; Wang P; Liu Y; Wang S; Yang C; Gu L
    BMC Microbiol; 2021 Dec; 21(1):342. PubMed ID: 34903163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocardiosis at the turn of the century.
    Minero MV; Marín M; Cercenado E; Rabadán PM; Bouza E; Muñoz P
    Medicine (Baltimore); 2009 Jul; 88(4):250-261. PubMed ID: 19593231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and antimicrobial susceptibility of referred
    Yeoh K; Globan M; Naimo P; Williamson DA; Lea K; Bond K
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35976092
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology and Antimicrobial Resistance Profiles of the
    Wang H; Zhu Y; Cui Q; Wu W; Li G; Chen D; Xiang L; Qu J; Shi D; Lu B
    Microbiol Spectr; 2022 Apr; 10(2):e0156021. PubMed ID: 35234511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
    Tan YE; Chen SC; Halliday CL
    J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations and outcome of nocardiosis and antimicrobial susceptibility of Nocardia species in southern Taiwan, 2011-2021.
    Yang CH; Kuo SF; Chen FJ; Lee CH
    J Microbiol Immunol Infect; 2023 Apr; 56(2):382-391. PubMed ID: 36456442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021.
    Yang J; Ren HT; Wang J; Dong AY; Chen YL; Hu DX; Wang H; Ji HM; Wen HN; Chen Y; Shi DY
    Int J Infect Dis; 2023 May; 130():136-143. PubMed ID: 36871785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species distribution and susceptibility of Nocardia isolates in New Zealand 2002-2021.
    McKinney WP; Smith MR; Roberts SA; Morris AJ
    Pathology; 2023 Aug; 55(5):680-687. PubMed ID: 37277236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility profiles of Nocardia isolates based on current taxonomy.
    Schlaberg R; Fisher MA; Hanson KE
    Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.
    Huang L; Chen X; Xu H; Sun L; Li C; Guo W; Xiang L; Luo G; Cui Y; Lu B
    Diagn Microbiol Infect Dis; 2019 Jun; 94(2):165-172. PubMed ID: 30679058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Analysis of Antimicrobial Susceptibility Profiles of
    Hamdi AM; Fida M; Deml SM; Abu Saleh OM; Wengenack NL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818815
    [No Abstract]   [Full Text] [Related]  

  • 18. Nocardiosis: 7-year experience at an Australian tertiary hospital.
    Paige EK; Spelman D
    Intern Med J; 2019 Mar; 49(3):373-379. PubMed ID: 30091232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Disseminated Nocardiosis Caused by
    Qiu F; Ma Z; Zhong R; Huang H; Wang Y; Liu H
    Front Public Health; 2022; 10():866420. PubMed ID: 35619805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece.
    Maraki S; Mavromanolaki VE; Kasimati A; Stafylaki D; Scoulica E
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):239-245. PubMed ID: 37459246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.